gadolinium dtpa has been researched along with Acute-On-Chronic Liver Failure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Liu, C; Liu, K; Ma, H; Shen, Z; Wang, X; Zhao, X; Zhu, Q | 1 |
Ambros, R; Ba-Ssalamah, A; Balcar, L; Bastati, N; Beer, L; Bican, Y; Binter, T; Hodge, JC; Kristic, A; Lauber, D; Mandorfer, M; Poetter-Lang, S; Pomej, K; Reiberger, T; Semmler, G; Simbrunner, B; Trauner, M; Wrba, T | 1 |
Du, YN; Guan, CS; Lv, ZB; Xie, RM; Xing, YX; Xue, M | 1 |
3 other study(ies) available for gadolinium dtpa and Acute-On-Chronic Liver Failure
Article | Year |
---|---|
Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Contrast Media; Gadolinium DTPA; Humans; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prognosis; Retrospective Studies | 2022 |
Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Topics: Acute-On-Chronic Liver Failure; Contrast Media; Gadolinium DTPA; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Spleen | 2022 |
T2-weighted imaging and dynamic contrast‑enhanced imaging in predicting the prognosis in patients with acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Ascites; Gadolinium DTPA; Gallbladder Diseases; Humans; Magnetic Resonance Imaging; Prognosis; Retrospective Studies | 2023 |